Home・Aktien・Schrodinger Inc

Schrodinger Inc

Geschlossen

BrancheGesundheitswesen

18.57 -0.38

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

18.17

Max

18.72

Schlüsselkennzahlen
By Trading Economics
Einkommen	66M 6M
Verkäufe	302K 59M
EPS	0.08
Gewinnspanne	10.146
Angestellte	850
EBITDA	65M 7.3M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+8.58% upside

Dividenden
By Acuity
Nächstes Ergebnis	4. Nov. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	217M 1.4B
Vorheriger Eröffnungskurs	18.95
Vorheriger Schlusskurs	18.57

Nachrichtenstimmung

By Acuity

72%

28%

299 / 340 Ranking in Healthcare

Schrodinger Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Aug. 2026, 19:16 UTC

Shares of Schrodinger Inc. are trading higher, maintaining a position above the 20-day moving average amid no specific company news.

10. Aug. 2026, 19:36 UTC

Schrodinger Inc's shares are higher today, continuing a six-day advance amid supportive market conditions and heightened geopolitical tensions affecting investor sentiment.

7. Aug. 2026, 19:16 UTC

Correlated Moves

Schrodinger Inc shares are higher today, supported by a broader market trend and gains in the Russell 2000 Index, despite some macroeconomic uncertainties.

6. Aug. 2026, 23:01 UTC

Schrodinger Inc shares declined in after-market trading, reversing gains from the previous four sessions. The stock remains above its 20-day moving average.

5. Aug. 2026, 23:01 UTC

News

Schrodinger Inc reported second-quarter adjusted EPS of $0.08, surpassing estimates. Revenue reached $58.889 million, leading to higher after-market trading.

3. Aug. 2026, 19:51 UTC

Correlated Moves

Schrodinger Inc shares are higher, reflecting broader market gains amid a drop in oil prices and positive sentiment in the technology sector.

31. Juli 2026, 19:46 UTC

Correlated Moves

Schrodinger Inc shares are lower amid declining first-quarter results and broader market pressure, despite an earlier rebound from session lows.

30. Juli 2026, 18:46 UTC

Correlated Moves

Schrodinger Inc. advanced during Thursday's session, supported by broader market gains despite earlier pulling back from a session high.

29. Juli 2026, 20:51 UTC

Correlated Moves

Schrodinger Inc shares are lower in after-market trading, influenced by a broader market downturn and rising crude oil prices amid geopolitical tensions.

28. Juli 2026, 23:01 UTC

Schrodinger Inc. shares declined in after-market trading, remaining below their 20-day moving average amid broader market strength and pressure on technology stocks.

27. Juli 2026, 22:51 UTC

Schrodinger Inc. shares are higher in after-market trading, despite remaining below their 20-day moving average amid broader market dynamics and falling crude oil prices.

24. Juli 2026, 15:11 UTC

Schrodinger Inc shares are declining today, continuing a downward trend since Thursday's close. A pullback in crude oil prices may be affecting investor sentiment.

20. Juli 2026, 15:12 UTC

Correlated Moves

Schrodinger Inc. shares are lower amid a decline in the ARK Genomic Revolution ETF and broader market pressures, despite a slight rebound earlier in the session.

Peer-Vergleich

Kursveränderung

Schrodinger Inc Prognose

Kursziel

By TipRanks

8.58% Vorteil

12-Monats-Prognose

Durchschnitt 20.25 USD 8.58%

Hoch 24 USD

Tief 17 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Schrodinger Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

6 ratings

Buy

Halten

Sell

Basierend auf 6 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Schrodinger Inc – Dist abgegeben haben.

Stimmung

By Acuity

299 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.